Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 August 2021 | Story Ruan Bruwer
Louzanne Coetzee at the Paralympics in Tokyo with her two guides, Claus Kempen (left) and Estean Badenhorst. She is one of 34 members in Team South Africa.

For some athletes, the postponement of the Paralympics was a big frustration, but for Louzanne Coetzee it was a ‘blessing in disguise’.

According to the former University of the Free State (UFS) student and current Residence Head of Akasia on the UFS Bloemfontein Campus, she was more than happy to get another 12 months to prepare herself to the very best of her ability. She will be in action at the Tokyo Paralympics in the 1 500 m on Sunday (29 August 2021) and Monday (30 August). On 5 September, she will tackle the marathon. It is her second Paralympics. 

“This is the most exited I have ever been for an event. It has been so long since I was able to compete on a high level. I think it is a blessing in disguise. It allowed me more time to prepare. I’m in a great state and I cannot wait,” she said.

In the 1 500 m, Coetzee will be guided by Estean Badenhorst. In the marathon she will run next to Claus Kempen, with whom she has completed a couple of marathons before.
“They are both very experienced and I’m fortunate to have such a great team with me. When you are running an event like the 1 500 m, you need to fully trust your guide with his decision making.”

“The main focus is the track item. I won’t put too much pressure on myself in the marathon. The prime goal is to gain experience in the longer distance, because that is where I’ll be shifting in the future,” she explained.

The South African 1 500 m record holder in the T11 classification (totally blind) clocked a personal best time of 4:51.65 in 2019. She is the world record holder in the 5 000 m; however, the item does not feature on the Paralympic programme. 

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept